Journal
PEDIATRIC BLOOD & CANCER
Volume 65, Issue 7, Pages -Publisher
WILEY
DOI: 10.1002/pbc.27011
Keywords
Ewing sarcoma; follow-up; imaging; recurrence; survival
Categories
Funding
- Stiftung fur krebskranke Kinder in Essen
- German Federal Ministry of Education and Research BMBF (TranSaRNet) [01ER0807]
- German Cancer Aid [DKH108128]
Ask authors/readers for more resources
BackgroundThe Cooperative Ewing Sarcoma Study and the Late Effects Surveillance System of the Society for Paediatric Oncology and Haematology recommend a structured follow-up imaging protocol (FUIP) for patients with Ewing sarcoma (EwS) with decreasing frequency of imaging over the first 5 years. The present study aims to assess the effectiveness of the FUIP for EwS patients regarding survival after relapse. Patients and methodsA retrospective multicenter analysis on 160 eligible patients with EwS recurrence was performed. Potential survival differences following recurrence diagnosis between patients with protocol-detected and symptomatic relapse were investigated using the Kaplan-Meier method. Additional subgroup analyses were performed on the relapse type. Overall survival (OS) was calculated from diagnosis of relapse to last follow-up or death. ResultsIn the multicenter analysis, recurrence was detected by FUIP in 77 of 160 patients (48%) and due to symptoms in 83 patients (52%). Regarding the entire study population, OS was significantly superior in patients with protocol-detected relapse compared to patients with symptomatic relapse (median, 2.4 vs. 1.2 years; P<0.001). In the subgroup analyses, patients whose lung recurrences were detected by the FUIP experienced longer survival after recurrence than those whose recurrences were detected symptomatically (P=0.023). In the 83 symptomatic patients, pain was the most prevalent symptom of relapse (72%). ConclusionFUIP may benefit survival in EwS relapse, especially in lung recurrence. Pain was the leading symptom of relapse.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available